Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications
Phase I study of 30-minute infusion of carfilzomib as single agent or in combination with low-dose dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 17, 2014
Showing 1-1 of 1
Last Updated: 09/26/2026